Provided by Tiger Trade Technology Pte. Ltd.

Kymera Therapeutics, Inc.

82.07
-2.1200-2.52%
Post-market: 82.070.00000.00%16:10 EST
Volume:1.10M
Turnover:90.70M
Market Cap:6.55B
PE:-22.81
High:84.23
Open:83.36
Low:80.78
Close:84.19
52wk High:103.00
52wk Low:19.45
Shares:79.79M
Float Shares:54.63M
Volume Ratio:0.56
T/O Rate:2.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5975
EPS(LYR):-2.9830
ROE:-32.09%
ROA:-19.21%
PB:6.92
PE(LYR):-27.51

Loading ...

Company Profile

Company Name:
Kymera Therapeutics, Inc.
Exchange:
NASDAQ
Establishment Date:
2015
Employees:
225
Office Location:
500 North Beacon Street,4th Floor,Watertown,Massachusetts,United States
Zip Code:
02472
Fax:
- -
Introduction:
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, general pustular psoriasis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

Directors

Name
Position
Bruce Booth
Chairman
Nello Mainolfi
President, Chief Executive Officer and Director
Felix J. Baker
Lead Independent Director
Elena Ridloff
Director
Gorjan Hrustanovic
Director
Jeffrey Albers
Director
John Maraganore
Director
Pamela Esposito
Director
Victor Sandor
Director

Shareholders

Name
Position
Nello Mainolfi
President, Chief Executive Officer and Director
Jeremy Chadwick
Chief Operating Officer
Bruce Jacobs
Chief Financial Officer
Brian R. Adams
Chief Legal Officer
Jared Gollob
Chief Medical Officer
Noah Goodman
Chief Business Officer